CHD1L expression is correlated with tumor size and stage in bladder cancer [25], nasopharyngeal carcinoma [27] and pancreatic cancer [65] in contrast to HCC [17] and ovarian cancer [23]. The gene discussed is CHD1L; the disease is nasopharyngeal carcinoma.